Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 14.2B | 12.3B | 11.5B |
Cost of revenue | — | 8.8B | 6.8B | 6.1B |
Gross profit | — | 5.4B | 5.4B | 5.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 1.6B | 1.3B | 1.3B |
Other operating expenses | — | 346.2M | 7.9M | -464.2M |
Operating income | — | 3.2B | 4.1B | 4.6B |
Non operating interest income | ||||
Income | — | 385.7M | 420.9M | 456.9M |
Expense | — | 1.5B | 1.6B | 1.2B |
Other income expense | — | -13.1B | 2.0B | -10.4B |
Pretax income | — | -11.1B | 5.0B | -6.5B |
Tax provision | — | -4.4B | 1.7B | -2.7B |
Net income | — | -6.7B | 3.2B | -3.8B |
Basic EPS | — | — | 2.6 | -2.9 |
Diluted EPS | — | — | 2.6 | -2.9 |
Basic average shares | 1.2B | — | 1.3B | 1.3B |
Diluted average shares | 1.2B | — | 1.3B | 1.3B |
EBITDA | — | 6.3B | 6.8B | 7.2B |
Net income from continuing op. | 6.3B | -6.7B | 3.2B | -3.8B |
Minority interests | — | -7.1M | -13.1M | -4.7M |
Preferred stock dividends | — | — | — | — |